General MedicationsORAL-28Generic
NORLESTRIN FE 2.5/50
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
Standard Dose
0.05MG;75MG;2.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NORLESTRIN FE 2.5/50 is listed in Drugs@FDA under application 016854 (NDA).
Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE Form and strength TABLET;ORAL-28 - 0.05MG;75MG;2.5MG Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NORLESTRIN FE 2.5/50 is listed in Drugs@FDA under application 016854 (NDA). Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE Form and strength TABLET;ORAL-28 - 0.05MG;75MG;2.5MG Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.